Unnamed: 0,title,date,stock,sentiment
1323819.0,61 Stocks Moving In Wednesday's Mid-Day Session,2020-06-10 13:31:00-04:00,VRML,neutral
1323820.0,Why Vermillion's Stock Is Trading Higher Today,2020-06-10 11:06:00-04:00,VRML,neutral
1323821.0,"Vermillion shares are trading higher after the company announced it completed validation of new pre-surgical test offerings with OVA1 plus, including coronavirus antibody testings. The company is also expected to join the Russell 3000 Index on June 29.",2020-06-10 08:29:00-04:00,VRML,positive
1323822.0,"Vermillion Completes Validation Of New Pre-Surgical Test Offerings With OVA1plus, Including COVID-19 Antibody Testing And Additional Pelvic Mass Risk Assessment Biomarkers",2020-06-10 08:07:00-04:00,VRML,negative
1323823.0,20 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-06-10 07:35:00-04:00,VRML,neutral
1323824.0,"The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset",2020-06-10 07:30:00-04:00,VRML,positive
1323825.0,90 Biggest Movers From Yesterday,2020-06-10 05:46:00-04:00,VRML,neutral
1323826.0,Vermillion Set To Join Russell 3000 Index,2020-06-09 16:35:00-04:00,VRML,positive
1323827.0,77 Biggest Movers From Yesterday,2020-06-05 05:18:00-04:00,VRML,neutral
1323828.0,60 Stocks Moving In Thursday's Mid-Day Session,2020-06-04 12:26:00-04:00,VRML,neutral
1323829.0,"The Daily Biotech Pulse: Regulatory Delay For Novartis' Multiple Sclerosis Drug, FSD Gets Nod For COVID-19 Study",2020-06-03 07:39:00-04:00,VRML,negative
1323830.0,Stocks That Hit 52-Week Highs On Tuesday,2020-06-02 10:33:00-04:00,VRML,neutral
1323831.0,"The Daily Biotech Pulse: FDA Nod For Roche's Combo Therapy In Liver Cancer, Allena Rips Higher, Pfizer To Invest Up To $500M In Biotechs",2020-06-02 07:45:00-04:00,VRML,negative
1323832.0,71 Biggest Movers From Yesterday,2020-06-02 04:39:00-04:00,VRML,neutral
1323833.0,Stocks That Hit 52-Week Highs On Friday,2020-05-29 10:36:00-04:00,VRML,neutral
1323834.0,"The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant",2020-05-29 07:22:00-04:00,VRML,positive
1323835.0,65 Biggest Movers From Yesterday,2020-05-29 05:35:00-04:00,VRML,neutral
1323836.0,Stocks That Hit 52-Week Highs On Thursday,2020-05-28 10:39:00-04:00,VRML,neutral
1323837.0,"The Daily Biotech Pulse: PhaseBio To Start Potential Pivotal COVID-19 Trial, Immunomedics CEO Quits, Tetraphase Receives Sweetened Offer",2020-05-28 08:24:00-04:00,VRML,neutral
1323838.0,Stocks That Hit 52-Week Highs On Wednesday,2020-05-27 10:39:00-04:00,VRML,neutral
1323839.0,71 Biggest Movers From Friday,2020-05-26 04:30:00-04:00,VRML,neutral
1323840.0,"The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test",2020-05-20 08:12:00-04:00,VRML,neutral
1323841.0,"The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering",2020-05-19 08:24:00-04:00,VRML,positive
1323842.0,62 Stocks Moving In Monday's Mid-Day Session,2020-05-18 12:43:00-04:00,VRML,neutral
1323843.0,Stocks That Hit 52-Week Highs On Monday,2020-05-18 10:44:00-04:00,VRML,neutral
1323844.0,70 Biggest Movers From Friday,2020-05-18 04:47:00-04:00,VRML,neutral
1323845.0,Stocks That Hit 52-Week Highs On Friday,2020-05-15 10:33:00-04:00,VRML,neutral
1323846.0,"Vermillion Q1 EPS $(0.040) Up From $(0.050) YoY, Sales $1.220M Beat $922.000K Estimate",2020-05-14 16:04:00-04:00,VRML,neutral
1323847.0,"The Daily Biotech Pulse: ASCO Abstracts Create Stock Ripples, Applied DNA's Coronavirus Test Receives EUA, Biopharmx Shareholders Vet Reverse Merger",2020-05-14 08:32:00-04:00,VRML,positive
1323848.0,"The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight",2020-05-10 15:40:00-04:00,VRML,neutral
1323849.0,"The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle",2020-05-06 08:42:00-04:00,VRML,positive
1323850.0,Stocks That Hit 52-Week Highs On Tuesday,2020-05-05 10:48:00-04:00,VRML,neutral
1323851.0,"The Daily Biotech Pulse: Bio-Rad's Coronavirus Test Gets EUA, Beat-And-Raise Quarter From GenMark, Adverum's Positive Gene Therapy Readout",2020-05-05 08:00:00-04:00,VRML,positive
1323852.0,"The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update",2020-04-28 07:36:00-04:00,VRML,neutral
1323853.0,Stocks That Hit 52-Week Highs On Monday,2020-04-27 10:21:00-04:00,VRML,neutral
1323854.0,"The Daily Biotech Pulse: FDA Approves Sanofi's Meningococcal Vaccine, Pluristem Secures $54M In Funding For COVID-19 Treatment, Oric Pharma Prices IPO",2020-04-24 08:38:00-04:00,VRML,positive
1323855.0,Vermillion Inc. Announces Its ASPiRA LABS Subsidiary Is Now Credentialed As Florida State Medicaid Provider,2020-04-14 08:11:00-04:00,VRML,neutral
1323856.0,"Vermillion Announces Cigna Preferred Contract Coverage For OVA1, Overa And Genetics Testing",2020-03-27 08:01:00-04:00,VRML,neutral
1323857.0,"Vermillion Q4 EPS $(0.03) Up From $(0.04) YoY, Sales $1.308M Beat $922K Estimate",2020-03-26 16:02:00-04:00,VRML,neutral
1323858.0,"The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Xencor Licenses Tech To Vir For COVID-19 Treatment, Delay In Pfizer's Upjohn-Mylan Merger",2020-03-26 08:23:00-04:00,VRML,negative
1323859.0,"The Week Ahead In Biotech: Bristol-Myers, Rockwell Medical Await FDA Decisions, COVID-19 Updates In Focus",2020-03-22 14:25:00-04:00,VRML,positive
1323860.0,"GenomeSmartTM and ASPiRA LABS, a Vermillion Company, Launch Pilot Program to Improve Access to Genetic Testing",2019-12-03 06:06:00-05:00,VRML,positive
1323861.0,"Vermillion Q3 EPS $(0.04), Same YoY, Sales $1.285M Beat $922K Estimate",2019-11-12 16:20:00-05:00,VRML,neutral
1323862.0,"The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat",2019-11-12 07:20:00-05:00,VRML,neutral
1323863.0,Vermillion Highlights 2 Independent Publications Showing OVA1 Demonstrates Improved Ovarian Malignancy Risk Detection In African-American Women,2019-09-04 08:07:00-04:00,VRML,positive
1323864.0,50 Healthcare Stocks Moving In Thursday's After-Market Session,2019-08-08 21:56:00-04:00,VRML,neutral
1323865.0,"Vermillion Q2 EPS $(0.06) Down From $(0.04) YoY, Sales $1.142M Beat $922K Estimate",2019-08-08 16:16:00-04:00,VRML,neutral
1323866.0,Vermillion Prices 18.75M Share Common Stock Offering At $0.80/Share,2019-06-26 09:15:00-04:00,VRML,positive
1323867.0,28 Stocks Moving In Wednesday's Pre-Market Session,2019-06-26 08:08:00-04:00,VRML,neutral
1323868.0,"The Daily Biotech Pulse: Decision Day For Regeneron-Sanofi, Vermillion Offering, PDL BioPharma CFO to Depart",2019-06-26 07:19:00-04:00,VRML,neutral
1323869.0,"8 Stocks To Watch For June 26, 2019",2019-06-26 04:48:00-04:00,VRML,neutral
1323870.0,5 Stocks Moving In Tuesday's After-Hours Session,2019-06-25 17:03:00-04:00,VRML,neutral
1323871.0,Vermillion shares are trading lower after the company filed for a common stock offering with no disclosed size.,2019-06-25 16:05:00-04:00,VRML,negative
1323872.0,"Vermillion Reports Offering Of Common Stock, No Size Disclosed",2019-06-25 16:02:00-04:00,VRML,negative
1323873.0,68 Biggest Movers From Friday,2019-06-24 04:25:00-04:00,VRML,neutral
1323874.0,44 Stocks Moving In Friday's Mid-Day Session,2019-06-21 12:13:00-04:00,VRML,neutral
1323875.0,Vermillion shares are trading higher after the company announced it added two major contracted agreements for OVA1.,2019-06-21 10:28:00-04:00,VRML,positive
1323876.0,Shares of several healthcare companies are trading higher with the overall US market. Recent comments out of China and Mexico has renewed trade optimism and lifted economic outlook.,2019-06-04 13:07:00-04:00,VRML,positive
1323877.0,"Vermillion Q1 EPS $(0.05), Same YoY, Sales $803K Miss $922K Estimate",2019-05-14 16:26:00-04:00,VRML,negative
1323878.0,"The Daily Biotech Pulse: Further Delay in Roche's Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings",2019-05-14 07:42:00-04:00,VRML,positive
1323879.0,"The Daily Biotech Pulse: J&J Earnings, FDA Nod For Medicinova, Proteon To Explore Strategic Alternatives",2019-04-16 08:10:00-04:00,VRML,neutral
1323880.0,"Vermillion Q4 EPS $(0.04) Up From $(0.05) YoY, Sales $922K Miss $1.5M Estimate",2019-03-28 16:19:00-04:00,VRML,negative
1323881.0,"The Daily Biotech Pulse: Blueprint Medicine Expedites Clinical Programs, Eyepoint Offering, Precision Biosciences IPO",2019-03-28 07:54:00-04:00,VRML,neutral
1323882.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs",2019-03-23 12:20:00-04:00,VRML,neutral
1323883.0,Vermillion Announces Coverage By Cigna For OVA1,2019-01-15 09:47:00-05:00,VRML,neutral
1323884.0,"The Daily Biotech Pulse: Tracon Aces Early-Stage Trials, Boston Scientific To Buy Out Millipede",2018-12-27 07:51:00-05:00,VRML,neutral
1323885.0,"The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas",2018-12-19 07:46:00-05:00,VRML,positive
1323886.0,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan",2018-12-18 08:00:00-05:00,VRML,positive
1323887.0,Health insurers and healthcare providers are trading down today after a Texas court ruled that ObamaCare was unconstitutional.,2018-12-17 11:06:00-05:00,VRML,neutral
1323888.0,"Vermillion, Inc. Q3 EPS $(0.04) Up From $(0.06) YoY, Sales $774K Miss $1.4M Estimate",2018-11-08 16:48:00-05:00,VRML,negative
1323889.0,"The Daily Biotech Pulse: Nantkwest Reports Positive Cancer Vaccine Trial Results, Sarepta Offering",2018-11-08 08:10:00-05:00,VRML,negative
1323890.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-04 13:35:00-05:00,VRML,neutral
1323891.0,"Stocks Which Set New 52-Week Low Yesterday, August 14th",2018-08-15 12:34:00-04:00,VRML,negative
1323892.0,"The Daily Biotech Pulse: Vertex Awaits FDA Verdict, Strongbridge Falls On Offering, ReShape's Woes Continue",2018-08-15 08:48:00-04:00,VRML,negative
1323893.0,"Vermillion Q2 EPS $(0.04), Inline, Sales $708K Miss $1M Estimate",2018-08-09 16:23:00-04:00,VRML,negative
1323894.0,"Stocks Which Set New 52-Week Low Yesterday, July 31",2018-08-01 12:16:00-04:00,VRML,negative
1323895.0,"Benzinga's Daily Biotech Pulse: Amgen Resubmits Osteoporosis Drug BLA, Auris Medical Prices Offering",2018-07-13 08:34:00-04:00,VRML,neutral
1323896.0,"Benzinga's Daily Biotech Pulse: Titan's Parkinson's Disease Drug Implant Trial, Juniper Pharma Sells Itself At 32% Premium",2018-07-03 07:51:00-04:00,VRML,neutral
1323897.0,42 Stocks Moving In Thursday's Mid-Day Session,2018-05-24 13:31:00-04:00,VRML,neutral
1323898.0,"Benzinga's Top Upgrades, Downgrades For May 24, 2018",2018-05-24 09:40:00-04:00,VRML,positive
1323899.0,"The Market In 5 Minutes: GE, Tariffs, Summit, Jobless Claims And More",2018-05-24 09:05:00-04:00,VRML,neutral
1323900.0,Canaccord Genuity Downgrades Vermillion to Hold,2018-05-24 06:19:00-04:00,VRML,neutral
1323901.0,"Vermillion Q1 EPS $(0.05) Misses $(0.04) Estimate, Sales $649K Miss $1.4M Estimate",2018-05-14 16:18:00-04:00,VRML,negative
1323902.0,40 Biggest Movers From Friday,2018-04-16 05:19:00-04:00,VRML,neutral
1323903.0,30 Stocks Moving In Friday's Mid-Day Session,2018-04-13 12:17:00-04:00,VRML,neutral
1323904.0,28 Stocks Moving In Friday's Pre-Market Session,2018-04-13 08:12:00-04:00,VRML,neutral
1323905.0,"8 Stocks To Watch For April 13, 2018",2018-04-13 05:04:00-04:00,VRML,neutral
1323906.0,"Vermillion Announces Proposed Concurrent Offering Of Common and Preferred Stock, No Size Disclosed",2018-04-12 16:45:00-04:00,VRML,negative
1323907.0,"Vermillion Reports Q4 EPS $(0.05) vs $(0.04) Est., Sales $798K vs $1.1M Est.",2018-03-13 16:03:00-04:00,VRML,neutral
1323908.0,Vermillion Reports Deal With BlueCross BlueShield Of Illinois,2018-01-18 08:48:00-05:00,VRML,neutral
1323909.0,"Vermillion Reports Q3 EPS $(0.06) vs $(0.04 ) Est., Sales $699K vs $900K Est.",2017-11-08 16:21:00-05:00,VRML,neutral
1323910.0,45 Biggest Movers From Yesterday,2017-11-02 05:23:00-04:00,VRML,neutral
1323911.0,40 Stocks Moving In Wednesday's Mid-Day Session,2017-11-01 12:40:00-04:00,VRML,neutral
1323912.0,Vermillion's ASPiRA Labs Reports OVA1 Contract With BCBS Of Louisiana,2017-10-31 08:46:00-04:00,VRML,neutral
1323913.0,Vermillion Subsidiary ASPiRA Labs Enters In-Network Contract Agreement with HealthNet Federal Services Effective 1/1/18,2017-10-02 16:45:00-04:00,VRML,positive
1323914.0,"Vermillion Reports Q2 EPS $(0.04) In-line With Est., Sales $860K vs $900K Est.",2017-08-09 16:02:00-04:00,VRML,neutral
1323915.0,"Vermillion Reports Q1 EPS $(0.05) vs $(0.04) Est., Sales $726K vs $1.1M Est.",2017-05-11 08:09:00-04:00,VRML,neutral
1323916.0,"Vermillion Reports Q4 EPS $(0.05) In-line With Estimates, Sales $805K vs $900K Est.",2017-03-29 16:03:00-04:00,VRML,neutral
1323917.0,"Earnings Scheduled For March 29, 2017",2017-03-29 04:45:00-04:00,VRML,neutral
1323918.0,Vermillion Co. ASPiRA LABs Announces It Attained Out-Of-State Provider With Medi-CAL For OVA1/Multivariate Index Assay,2017-03-06 16:15:00-05:00,VRML,neutral
1323919.0,25 Biggest Mid-Day Gainers For Thursday,2017-03-02 12:39:00-05:00,VRML,neutral
1323920.0,Mid-Morning Market Update: Markets Edge Lower; Abercrombie & Fitch Earnings Miss Views,2017-03-02 10:00:00-05:00,VRML,negative
1323921.0,25 Stocks Moving In Thursday's Pre-Market Session,2017-03-02 08:14:00-05:00,VRML,neutral
1323922.0,18 Biggest Mid-Day Gainers For Tuesday,2017-02-21 12:38:00-05:00,VRML,neutral
1323923.0,"VERMILLION, INC.: Burns James S (Director) Buys 26,250 @ Avg Price: $0.85 (Form4)",2017-02-15 15:54:00-05:00,VRML,neutral
1323924.0,18 Biggest Mid-Day Gainers For Tuesday,2017-02-14 12:28:00-05:00,VRML,neutral
1323925.0,Vermillion Reports $5.6M in Equity Financing,2017-02-14 08:32:00-05:00,VRML,neutral
1323926.0,Vermillion Annnounces Receipt of Formal FDA Clarification Regarding OVA1 And Overa,2017-01-04 16:06:00-05:00,VRML,neutral
1323927.0,Vermillion Announces Appointment of Chief Medical Officer Dr. Marra Francis,2016-11-14 17:02:00-05:00,VRML,neutral
1323928.0,"Vermillion Reports Q3 EPS $(0.07) vs $(0.06) Est., Sales $623K vs $900K Est.",2016-11-10 16:05:00-05:00,VRML,neutral
1323929.0,UPDATE: Vermillion Announces ASPiRA LABs Supports FDA's Recommendation Against Use of Any Screening Tests for Ovarian Cancer,2016-09-09 07:32:00-04:00,VRML,negative
1323930.0,Vermillion and ASPiRA LABs Applaud the FDA's Position on Ovarian Cancer Screening,2016-09-09 07:32:00-04:00,VRML,negative
1323931.0,"Vermillion Reports Q2 EPS $(0.07) vs $(0.09) Est., Sales $709K vs $600K Est.",2016-08-10 07:32:00-04:00,VRML,neutral
1323932.0,"Vermillion Reports Inline Q1 EPS $(0.09), Sales $505K Vs Est $400K",2016-05-16 16:02:00-04:00,VRML,neutral
1323933.0,"Earnings Scheduled For May 16, 2016",2016-05-16 04:30:00-04:00,VRML,neutral
1323934.0,Vermillion Announces Publication of First OVA1® Clinical Utility Study,2016-04-19 16:02:00-04:00,VRML,neutral
1323935.0,"Vermillion Reports Received $2M Disbursement of Up to $4M Loan from Connecticut Dept. of Economic, Community Development",2016-04-18 16:02:00-04:00,VRML,neutral
1323936.0,Vermillion Reports Q4 EPS $(0.10) vs. Est. $(0.11),2016-03-24 08:02:00-04:00,VRML,neutral
1323937.0,"Earnings Scheduled For March 24, 2016",2016-03-24 04:06:00-04:00,VRML,neutral
1323938.0,"Vermillion Announces FDA Clearance of Overa, Second Generation OVA1 Test",2016-03-21 08:15:00-04:00,VRML,neutral
1323939.0,"Vermillion Reports Q3 EPS $(0.10) Vs Est $(0.11), Sales $330K Vs Est $780K",2015-11-12 08:11:00-05:00,VRML,neutral
1323940.0,"Vermillion Reports Q1 Loss $0.15 Vs Loss $0.09, Sales $535K Vs Est $1.15M",2015-08-13 09:00:00-04:00,VRML,negative
1323941.0,Benzinga's Top Initiations,2015-08-11 09:45:00-04:00,VRML,positive
1323942.0,"Canaccord Genuity Initiates Coverage on Vermillion at Buy, Announces $4.00 PT",2015-08-11 07:50:00-04:00,VRML,neutral
1323943.0,Vermillion Prices 8.4M Shares at $1.96/Share,2015-07-14 09:00:00-04:00,VRML,positive
1323944.0,Vermillion Announces Offering of Common Shares,2015-07-13 16:01:00-04:00,VRML,positive
1323945.0,Vermillion Approved for a $7.5M Grant by the Cancer Prevention and Research Institute of Texas,2015-05-21 09:01:00-04:00,VRML,neutral
1323946.0,Positive Top-Line Results Regarding OVA2 Development and Clinical Validation,2015-05-14 09:21:00-04:00,VRML,positive
1323947.0,"Vermillion Reports Inline Q1 Loss $0.10, Sales $951K Vs Est $800.0K",2015-05-11 16:16:00-04:00,VRML,negative
1323948.0,Kaiser Permanente Southern California and Vermillion Collaborate to Improve Best-Practice Care for Women with Ovarian Cancer,2015-04-14 09:05:00-04:00,VRML,positive
1323949.0,Vermillion Reports Landmark OVA1 Cost-Effectiveness Analysis Compared to Current Standard at ACMQC,2015-03-27 08:02:00-04:00,VRML,positive
1323950.0,"Vermillion Reports Q4 EPS -$0.11, Sales $1.57M, No Estimates Available",2015-03-25 08:01:00-04:00,VRML,negative
1323951.0,Stocks Hitting 52-Week Highs,2015-03-18 10:08:00-04:00,VRML,neutral
1323952.0,Morning Market Gainers,2015-03-18 09:43:00-04:00,VRML,neutral
1323953.0,UPDATE: Vermillion Entered Into 3 Agreements With Quest Diagnostics,2015-03-17 16:22:00-04:00,VRML,positive
1323954.0,"Vermillion Says on March 11, 2015 Co, Unit Entered Into Three Agreements With Quest Diagnostics",2015-03-17 16:14:00-04:00,VRML,positive
1323955.0,"Top Performing Industries For March 16, 2015",2015-03-16 10:21:00-04:00,VRML,positive
1323956.0,Vermillion Receives ISO 13485 Certification For Its Management System,2015-02-12 16:23:00-05:00,VRML,neutral
1323957.0,Benzinga's Top Initiations,2015-02-09 09:25:00-05:00,VRML,positive
1323958.0,Roth Capital Initiates Vermillion With Buy,2015-02-09 08:57:00-05:00,VRML,neutral
1323959.0,"Roth Capital Initiates Coverage on Vermillion at Buy, Announces $4.00 PT",2015-02-09 06:32:00-05:00,VRML,neutral
1323960.0,"Matthew Strobeck Shows 7.5% Stake in Vermillion, Up From 0.09%",2015-01-22 15:47:00-05:00,VRML,neutral
1323961.0,Vermillion Appoints Laura Miller as SVP of Sales/Customer Experience,2015-01-12 09:10:00-05:00,VRML,neutral
1323962.0,"Vermillion Shareholder Schuler Buys 1,288,339 Shares @$1.44/Share -Form 4",2014-12-29 11:22:00-05:00,VRML,positive
1323963.0,Vermillion Receives Equity Financing Of $18.9M; Suspends ATM Program,2014-12-23 09:18:00-05:00,VRML,neutral
1323964.0,Vermillion Appoints Valerie Palmieri As CEO; James LaFrance To Remain As Chairman,2014-12-16 16:10:00-05:00,VRML,neutral
1323965.0,"Vermillion, Inc. Reports Q3 EPS of $(0.16), Down 23% YOY; Revenue of $323.0K, Up 1% YOY",2014-11-13 16:04:00-05:00,VRML,neutral
1323966.0,"Top Performing Industries For October 24, 2014",2014-10-24 10:36:00-04:00,VRML,positive
1323967.0,"Vermillion, Inc. Reports Q2 EPS of $(0.15), Down 15% YOY; Revenue of $324.0K, Up 1% YOY",2014-08-14 16:22:00-04:00,VRML,neutral
1323968.0,"Vermillion, Inc. Reports Q1 EPS of $(0.11), Up 15% YOY; Revenue of $305.0K, Down 5% YOY",2014-05-15 16:12:00-04:00,VRML,neutral
1323969.0,"Vermillion Appoints LaFrance as President, CEO",2014-04-23 16:06:00-04:00,VRML,neutral
1323970.0,"Vermillion, Inc. Reports Q4 EPS of $(0.07) vs $(0.15) Est; Revenue of $1.59M vs $300.0K Est",2014-03-06 16:09:00-05:00,VRML,neutral
1323971.0,Vermillion Appoints Marian E. Sacco as SVP of Sales and Marketing and Chief Commercial Officer,2013-12-17 16:01:00-05:00,VRML,neutral
1323972.0,"Vermillion, Inc. Reports Q3 EPS of $(0.10), Up 23% YOY; Revenue of $330.0K, Up 3% YOY",2013-11-14 16:02:00-05:00,VRML,neutral
1323973.0,Vermillion Appoints Dr. Eric Varma to its Board of Directors,2013-09-16 16:03:00-04:00,VRML,neutral
1323974.0,"Vermillion, Inc. Reports Q2 EPS of $(0.11) vs $(0.15) Est; Revenue of $323.0K vs $300.0K Est",2013-08-14 16:05:00-04:00,VRML,neutral
1323975.0,"Earnings Scheduled For May 15, 2013 ",2013-05-15 04:39:00-04:00,VRML,neutral
1323976.0,Morning Market Movers ,2013-05-09 10:23:00-04:00,VRML,neutral
1323977.0,Stocks Hitting 52-Week Lows,2013-04-08 11:37:00-04:00,VRML,negative
1323978.0,Vermillion Appoints Thomas McLain as President and CEO,2013-03-13 08:33:00-04:00,VRML,neutral
1323979.0,"Vermillion, Inc. Reports Q4 EPS of $(0.09) vs $(0.12) Est; Revenue of $1.10M vs $900.0K Est",2013-02-20 16:37:00-05:00,VRML,neutral
1323980.0,"Benzinga's Small Cap Movers for Wednesday November 28, 2012 ",2012-11-28 20:24:00-05:00,VRML,neutral
1323981.0,UPDATE: Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of Vermillion's OVA,2012-11-28 10:49:00-05:00,VRML,positive
1323982.0,"Vermillion Shares Resume, Now Up 40%",2012-11-28 10:49:00-05:00,VRML,positive
1323983.0,Vermillion Shares Halted on Circuit Breaker Following News of Positive Study Results of OVA1,2012-11-28 10:45:00-05:00,VRML,positive
1323984.0,Vermillion Names Bruce Huebner Interim CEO,2012-11-27 08:42:00-05:00,VRML,neutral
1323985.0,Vermillion Reports Q3 EPS $-0.13 vs $-0.20 Est; Revenues $319K vs $320.00K Est,2012-11-12 16:09:00-05:00,VRML,neutral
1323986.0,"Earnings Scheduled For November 12, 2012",2012-11-12 02:29:00-05:00,VRML,neutral
1323987.0,Ladenburg Thalmann Upgraded Vermillion from Sell to Neutral,2012-10-25 10:54:00-04:00,VRML,neutral
1323988.0,Vermillion Reports Q2 EPS $-0.13 vs $-0.20 Est; Revenues $321K vs $320.00K Est,2012-08-14 16:50:00-04:00,VRML,neutral
1323989.0,Vermillion Announces Positive Top-Line Results from the OVA500 Multi-Center Study Led by UC Irvine ,2012-07-30 08:31:00-04:00,VRML,positive
1323990.0,Mid-Day Market Losers,2012-05-25 13:08:00-04:00,VRML,negative
1323991.0,Mid-Day Market Losers,2012-05-25 12:17:00-04:00,VRML,negative
1323992.0,"Benzinga's Microcap Movers for Thursday May 24, 2012",2012-05-25 07:13:00-04:00,VRML,neutral
1323993.0,Vermillion Trading 33.7% Higher on Heavy Volume; Currently at $2.46,2012-05-24 15:33:00-04:00,VRML,neutral
1323994.0,"Rosetta Genomics Surges, Shares Rise 1000% in 8 Trading Days",2012-05-24 12:19:00-04:00,VRML,positive
1323995.0,Vermillion Trading 18.5% Higher on Heavy Volume; Currently at $2.18,2012-05-24 10:38:00-04:00,VRML,neutral
1323996.0,Vermillion Announces CEO Succession Plan ,2012-05-15 16:21:00-04:00,VRML,positive
1323997.0,Vermillion Spokesperson Says Patent Award Reported Today Was Actually Announced March 5,2012-05-08 13:42:00-04:00,VRML,positive
1323998.0,UPDATE: Vermillion Awarded Patent for Platelet Biomarkers for Cancer ,2012-05-08 11:43:00-04:00,VRML,negative
1323999.0,Vermillion Spikes Higher on Award of Patent for Cancer Test,2012-05-08 11:41:00-04:00,VRML,negative
1324000.0,Vermillion Resolves Non-Contingent Claims with Bio-Rad; Vermillion to be Returned More Than $1M from Escrow  ,2012-04-30 08:32:00-04:00,VRML,positive
1324001.0,Vermillion Receives Notice of Allowance for Patent of Biomarker for Ovarian Cancer ,2012-04-16 08:33:00-04:00,VRML,negative
1324002.0,Vermillion Spiking Higher on Heavy Volume; Currently at $2.01,2012-04-03 11:25:00-04:00,VRML,neutral
1324003.0,Vermillion Rises 23% on Patent Allowance,2012-03-28 08:33:00-04:00,VRML,neutral
1324004.0,Vermillion Receives Notice of Allowance for Patent on Methods for Diagnosing Ovarian Cancer ,2012-03-28 08:30:00-04:00,VRML,negative
1324005.0,Ladenburg Thalmann Comments on Vermillion's 10-K Filing,2012-03-28 07:50:00-04:00,VRML,neutral
1324006.0,Morning Market Movers,2012-03-27 09:46:00-04:00,VRML,neutral
1324007.0,Earnings Roundup,2012-03-27 08:52:00-04:00,VRML,neutral
1324008.0,Vermillion Reports Q4 EPS $(0.21) vs $(0.26) Est; Revs $868K vs $770K Est,2012-03-27 06:45:00-04:00,VRML,neutral
1324009.0,Vermillion Spiking Higher on Heavy Volume; Currently at $1.93,2012-03-13 11:07:00-04:00,VRML,neutral
1324010.0,"Benzinga's M&A Chatter for Thursday March 8, 2012",2012-03-08 17:28:00-05:00,VRML,neutral
1324011.0,Vermillion Spiking Lower on Heavy Volume; Currently at $2.07,2012-03-08 10:41:00-05:00,VRML,negative
1324012.0,Vermillion Trading 12.6% Higher on Heavy Volume; Currently at $2.41,2012-03-08 09:36:00-05:00,VRML,neutral
1324013.0,Hearing B Riley Saying Vermillion is Takeover Target,2012-03-08 09:34:00-05:00,VRML,neutral
1324014.0,Benzinga's Top Downgrades,2012-03-07 08:36:00-05:00,VRML,positive
1324015.0,Benzinga's Top Pre-Market Losers,2012-03-07 08:30:00-05:00,VRML,negative
1324016.0,A Peek Into The Market Before The Trading Starts,2012-03-07 07:16:00-05:00,VRML,neutral
1324017.0,"Benzinga's Microcap Movers for Tuesday March 6, 2012 ",2012-03-06 20:23:00-05:00,VRML,neutral
1324018.0,Vermillion Nearly Doubles After Category 1 CPT Code Approval,2012-03-06 14:33:00-05:00,VRML,positive
1324019.0,Vermillion Trading 94.7% Higher on Heavy Volume; Currently at $2.59,2012-03-06 12:32:00-05:00,VRML,neutral
1324020.0,Vermillion Trading 67.7% Higher on Heavy Volume; Currently at $2.23,2012-03-06 11:37:00-05:00,VRML,neutral
1324021.0,Vermillion Receives Category 1 CPT Code Approval for OVA,2012-03-06 08:31:00-05:00,VRML,positive
1324022.0,"Wedbush Securities Maintains Vermillion at Outperform, Lowers PT from $4 to $3",2012-02-24 07:17:00-05:00,VRML,positive
1324023.0,Vermillion Sees Q4 Revenue of $113K vs $196K Year Ago ,2012-02-23 16:08:00-05:00,VRML,neutral
1324024.0,"Wedbush maintains its Outperform rating and $4 target on Vermillion (NASDAQ: VRML) ahead of the company's Q4 results, which are expected to be lackluster due to limited insight into Quest progress.",2012-02-21 08:36:00-05:00,VRML,positive
1324025.0,Vermillion Sharpens Focus and Streamlines Operations in 2012; To Reduce Headcount And Other Expenses,2012-01-04 08:25:00-05:00,VRML,neutral
1324026.0,"Benzinga's Microcap Movers for Tuesday January 3, 2012",2012-01-03 18:55:00-05:00,VRML,neutral
1324027.0,Vermillion Rises 18%; Company Spokesperson Says No News to Account for Move Today,2012-01-03 14:12:00-05:00,VRML,negative
1324028.0,"Ladenburg Thalmann Remains Neutral, Cuts Forecast on Vermillion",2011-11-10 08:07:00-05:00,VRML,negative
1324029.0,"Vermillion Hits New 52-Week Low, $1.63",2011-11-09 10:08:00-05:00,VRML,negative
1324030.0,Stocks Hitting 52-Week Lows,2011-10-11 12:07:00-04:00,VRML,negative
1324031.0,Hearing B Riley Initiates Vermillion with Buy and $8PT,2011-10-04 09:45:00-04:00,VRML,neutral
1324032.0,Wedbush Reiterates its Outperform rating on VRML,2011-10-04 09:15:00-04:00,VRML,neutral
1324033.0,Vermillion Announces Positive Top-Line Data from Intended Use Study for Peripheral Artery Disease (PAD) ,2011-10-03 08:31:00-04:00,VRML,positive
1324034.0,Vermillion Appoints Donald Munroe as Chief Scientific Officer,2011-09-26 08:33:00-04:00,VRML,neutral
1324035.0,Ladenburg Thalmann Initiates Vermillion At Neutral,2011-09-16 07:43:00-04:00,VRML,neutral
1324036.0,Vermillion Rises 22% Pre-Market on Ovarian Cancer Test Presentation,2011-09-14 09:06:00-04:00,VRML,negative
1324037.0,Vermillion Announces Issuance of Patent for Lung Cancer ,2011-09-06 08:00:00-04:00,VRML,negative
1324038.0,UPDATE: Vermilion Received Alzheimer's Patent,2011-08-09 10:21:00-04:00,VRML,neutral
1324039.0,Hearing Vermillion Gets Key Alzheimer Patent -markflowchatter,2011-08-09 10:20:00-04:00,VRML,neutral
1324040.0,Vermillion Appoints Distribution Partner for OVA1® in Israel and the Palestine Territories,2011-08-03 08:34:00-04:00,VRML,neutral
1324041.0,Vermillion Spiking Higher,2011-08-02 10:53:00-04:00,VRML,neutral
1324042.0,Vermillion Announces Notice of Allowance for Peripheral Artery Disease (PAD) Patent,2011-08-02 08:33:00-04:00,VRML,neutral
1324043.0,Vermillion Announces Notice of Allowance for Peripheral Artery Disease Patent ,2011-08-02 08:31:00-04:00,VRML,neutral
1324044.0,Vermillion Announces Notice of Allowance for Peripheral Artery Disease (PAD) Patent,2011-08-01 08:30:00-04:00,VRML,neutral
1324045.0,Hearing Positive Chatter in Vermillion; Shares Moving Higher,2011-07-11 10:44:00-04:00,VRML,positive
1324046.0,Top Percentage Gainers and Losers as of 12pm 06/17/11,2011-06-17 12:04:00-04:00,VRML,negative
1324047.0,Vermillion Spiking on Potential Deal Talk,2011-06-17 10:28:00-04:00,VRML,neutral
1324048.0,Top Percentage Gainers and Losers as of 2pm 06/14/11,2011-06-14 14:02:00-04:00,VRML,negative
1324049.0,High-Flying Stocks On My Radar,2011-06-07 09:08:00-04:00,VRML,neutral
1324050.0,Vermillion Spiking over 9% Higher on the Session,2011-06-06 11:14:00-04:00,VRML,neutral
1324051.0,Positive Rumors About Vermillion Circulate (VRML),2011-05-31 09:38:00-04:00,VRML,positive
1324052.0,Vermillion Announces Notice of Allowance for Alzheimer Patent,2011-05-25 08:32:00-04:00,VRML,neutral
1324053.0,Vermillion Trading Over 10% Higher After Reporting FDA News,2011-05-24 10:16:00-04:00,VRML,neutral
1324054.0,OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment,2011-05-24 09:22:00-04:00,VRML,negative
1324055.0,Hearing Manchester Management raises Vermillion stake to 5.2%,2011-05-20 11:31:00-04:00,VRML,neutral
1324056.0,Vermillion Holder Manchester Reports 5.2% Stake -Bloomberg  ,2011-05-19 15:35:00-04:00,VRML,neutral
1324057.0,Vermillion Announces the Appointment of Bruce Huebner to its Board of Directors,2011-05-19 08:35:00-04:00,VRML,neutral
1324058.0,Vermillion Announces Notice of Allowance for Peripheral Artery Disease Patent ,2011-05-17 08:37:00-04:00,VRML,neutral
1324059.0,"Top Percentage Gainers and Losers as of 2:15pm 5/16/2011 (VITA, SYK, CISG, TISA, ENOC, TSTC, SPMD, KNDI, ABIO, KONG, OXGN, VRML, PSTR, FXCM, ATRN, SYMX, GSL)",2011-05-16 14:15:00-04:00,VRML,negative
1324060.0,NASDAQ Top Percentage Gainers,2011-05-13 15:04:00-04:00,VRML,positive
1324061.0,NASDAQ Top Percentage Gainers,2011-05-13 15:03:00-04:00,VRML,positive
1324062.0,"Top Percentage Gainers and Losers as of 2pm 05/13/11 (ABIO, GFRE, DDS, APL, DF, VRML, DAR, SWSH, ONTY, GS, RMBS, LPHI, GGS, CA, NVDA, IMRS, MNTX, MPG, GTY)",2011-05-13 14:00:00-04:00,VRML,negative
1324063.0,"Top Percentage Gainers and Losers as of 12pm 5/13/11 (ABIO, DDS, GFRE, APL, VRML, DF, SWSH, CLSN, AERL, CA, NVDA, QTWW, IMRS, FFHL, MPG, GENE)",2011-05-13 12:04:00-04:00,VRML,negative
1324064.0,"Top day traders Stocks and nalyst Upgrades & Downgrades on 5/13/11- NVDA, PNSN, VRML, A, YHOO, DF",2011-05-13 09:49:00-04:00,VRML,positive
1324065.0,UPDATE: Vermillion Spikes +28% on the Open,2011-05-13 09:32:00-04:00,VRML,neutral
1324066.0,"NASDAQ Top Percentage Gainers; (NasdaqGM: TREE), (NasdaqGM: TZYM), (NasdaqGS: GFRE) and (NasdaqGM: VRML)",2011-05-13 09:00:00-04:00,VRML,positive
1324067.0,"NASDAQ Top Percentage Gainers; (NasdaqGM: TREE), (NasdaqGM: TZYM), (NasdaqGS: GFRE) and (NasdaqGM: VRML)",2011-05-13 09:00:00-04:00,VRML,positive
1324068.0,UPDATE: Vermillion Gains +19% in Pre-Market Trading,2011-05-13 08:28:00-04:00,VRML,positive
1324069.0,Wedbush Reaffirms Outperform Rating on Vermillion,2011-05-13 08:23:00-04:00,VRML,neutral
1324070.0,UPDATE: Vermillion Gains +13% in Pre-Market Trading,2011-05-13 08:15:00-04:00,VRML,positive
1324071.0,"Benzinga's Top Pre-Market NASDAQ Gainers (VRML, PNSN, EXPE, GOLD)",2011-05-13 08:14:00-04:00,VRML,positive
1324072.0,"CEOWORLD Most Popular Stocks on 5/13/11- CA, NVDA, VRML, JWN, ENB, PNSN, SFIO, PAY, HYC, TREE",2011-05-13 03:49:00-04:00,VRML,positive
1324073.0,OVA1 Blood Test Detects Ovarian Cancer More Accurately Than Medically Accepted CA 125 Method for Evaluating Women with Ovarian Mass,2011-05-12 14:05:00-04:00,VRML,negative
1324074.0,Wedbush Reports on Vermillion (VRML),2011-05-11 08:27:00-04:00,VRML,neutral
1324075.0,Wedbush Lowers PT on Vermillion To $7,2011-05-11 07:51:00-04:00,VRML,negative
1324076.0,"Top Percentage Gainers and Losers as of 2pm 5/10/11 (FONR, CKXE, TRAK, CPE, SREV, FFHL, MED, FOSL, BMTI, HEAT, PANL, MOBI, MNKD, VRML, USAT, ETM)",2011-05-10 14:07:00-04:00,VRML,negative
1324077.0,"Top Percentage Gainers and Losers as of 12pm 5/10/11 (FONR, TRAK, CKXE, CPE, FFHL MED, PTRY, GENE,BMTI, HEAT, PANL, USAT, HOLI,  ITMN, VRML)",2011-05-10 12:06:00-04:00,VRML,negative
1324078.0,Manchester Management Announces A 9.2% Stake In Vermillion (VRML),2011-04-18 15:50:00-04:00,VRML,neutral
1324079.0,Vermillion and Quest Diagnostics Sign Agreement to Make OVA1 Available in India ,2011-04-04 08:35:00-04:00,VRML,positive
1324080.0,Vermillion Announces Presentation of Positive Ovarian Biomarker Data ,2011-03-08 08:31:00-05:00,VRML,positive
1324081.0,Vermillion Announces $21.8M Public Offering ,2011-02-15 08:19:00-05:00,VRML,neutral
1324082.0,Vermillion Reports Q4 EPS of $(0.38) vs. $(0.35),2011-02-10 08:16:00-05:00,VRML,neutral
1324083.0,Vermillion Shares Climb 9% (VRML),2011-01-11 13:35:00-05:00,VRML,positive
1324084.0,Vermillion Falls 11.4% (VRML),2010-12-28 14:08:00-05:00,VRML,neutral
1324085.0,Vermillion Trading Up 27.47% Today (VRML),2010-12-27 13:43:00-05:00,VRML,neutral
1324086.0,"Monday's Most Advance Gainers NASDAQ; VRML. APWR, FlWS, ARSD, SPCHA",2010-12-27 11:39:00-05:00,VRML,neutral
1324087.0,Vermillion Shares Soar 22.5% (VRML),2010-12-27 11:32:00-05:00,VRML,positive
1324088.0,Vermillion Shares Soar 13.3% (VRML),2010-12-23 15:40:00-05:00,VRML,positive
1324089.0,5 Drug Stock Losers of 2010,2010-12-06 07:02:00-05:00,VRML,negative
1324090.0,Vermillion Reports Third Quarter EPS of $(0.26),2010-11-11 08:12:00-05:00,VRML,neutral
1324091.0,"Vermillion, Inc. Shares Soar 40% (VRML)",2010-11-08 14:35:00-05:00,VRML,positive
1324092.0,Vermillion Skyrocketing (VRML),2010-11-08 14:04:00-05:00,VRML,neutral
1324093.0,Vermillion Appoints Ashish Kohli as Vice President ,2010-09-29 08:09:00-04:00,VRML,neutral
